Wednesday, December 17, 2025
More
    HomeUS FDA approves Regeneron’s ultra-rare blood disease drugFILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on

    FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on

    FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid/File Photo

    Most Read